Novartis Pharma To Add Diagnostics Unit In 2009
This article was originally published in The Gray Sheet
Executive Summary
Novartis' Pharma division will establish a molecular diagnostics unit in 2009, Pharma CEO Joseph Jimenez said during the firm's Nov. 19 R&D day